239 related articles for article (PubMed ID: 15821472)
1. Higher than expected association of clinical prostate and bladder cancers.
Singh A; Kinoshita Y; Rovito PM; Landas S; Silberstein J; Nsouli I; Wang CY; Haas GP
J Urol; 2005 May; 173(5):1526-9. PubMed ID: 15821472
[TBL] [Abstract][Full Text] [Related]
2. Higher than expected association of clinical prostate and bladder cancers.
Singh A; Kinoshita Y; Rovito PM; Landas S; Silberstein J; Nsouli I; Wang CY; Haas GP
J Urol; 2008 May; 179(5 Suppl):S2-5. PubMed ID: 18405742
[TBL] [Abstract][Full Text] [Related]
3. Renal diagnosis of chronic hemodialysis patients with urinary tract transitional cell carcinoma in Taiwan.
Chang CH; Yang CM; Yang AH
Cancer; 2007 Apr; 109(8):1487-92. PubMed ID: 17330839
[TBL] [Abstract][Full Text] [Related]
4. Incidence and histological findings of unsuspected prostatic adenocarcinoma in radical cystoprostatectomy for transitional cell carcinoma of the bladder.
Moutzouris G; Barbatis C; Plastiras D; Mertziotis N; Katsifotis C; Presvelos V; Theodorou C
Scand J Urol Nephrol; 1999 Feb; 33(1):27-30. PubMed ID: 10100360
[TBL] [Abstract][Full Text] [Related]
5. Second primary cancers in men with prostate cancer: an increased risk of male breast cancer.
Thellenberg C; Malmer B; Tavelin B; Grönberg H
J Urol; 2003 Apr; 169(4):1345-8. PubMed ID: 12629357
[TBL] [Abstract][Full Text] [Related]
6. Comparative study on the prevalence of clinically detectable prostate cancer in patients with and without bladder cancer.
Kurokawa K; Ito K; Yamamoto T; Takechi H; Miyamoto S; Suzuki K; Yamanaka H
Urology; 2004 Feb; 63(2):268-72. PubMed ID: 14972469
[TBL] [Abstract][Full Text] [Related]
7. Risk assessment for occult malignancy in the prostate before radical cystectomy.
Kefer JC; Voelzke BB; Flanigan RC; Wojcik EM; Waters WB; Campbell SC
Urology; 2005 Dec; 66(6):1251-5. PubMed ID: 16360452
[TBL] [Abstract][Full Text] [Related]
8. Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer.
Chrouser K; Leibovich B; Bergstralh E; Zincke H; Blute M
J Urol; 2005 Jul; 174(1):107-10; discussion 110-1. PubMed ID: 15947588
[TBL] [Abstract][Full Text] [Related]
9. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
Nieder AM; Porter MP; Soloway MS
J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
[TBL] [Abstract][Full Text] [Related]
10. Association of colorectal cancer and prostate cancer and impact of radiation therapy.
Huo D; Hetzel JT; Roy H; Rubin DT
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):1979-85. PubMed ID: 19531678
[TBL] [Abstract][Full Text] [Related]
11. Familial papillary renal cell tumors and subsequent cancers: a nationwide epidemiological study from Sweden.
Czene K; Hemminki K
J Urol; 2003 Apr; 169(4):1271-5. PubMed ID: 12629341
[TBL] [Abstract][Full Text] [Related]
12. Incidental prostate cancer in radical cystoprostatectomy specimens.
Jin XD; Chen ZD; Wang B; Cai SL; Yao XL; Jin BY
Asian J Androl; 2008 Sep; 10(5):809-14. PubMed ID: 18645685
[TBL] [Abstract][Full Text] [Related]
13. High incidence of lung cancer after non-muscle-invasive transitional cell carcinoma of the bladder: implications for screening trials.
Rusthoven KE; Flaig TW; Raben D; Kavanagh BD
Clin Lung Cancer; 2008 Mar; 9(2):106-11. PubMed ID: 18501097
[TBL] [Abstract][Full Text] [Related]
14. Increasing age and treatment modality are predictors for subsequent diagnosis of bladder cancer following prostate cancer diagnosis.
Singh AK; Mashtare TL; McCloskey SA; Seixas-Mikelus SA; Kim HL; May KS
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1086-94. PubMed ID: 20350797
[TBL] [Abstract][Full Text] [Related]
15. A population study of neutering status as a risk factor for canine prostate cancer.
Bryan JN; Keeler MR; Henry CJ; Bryan ME; Hahn AW; Caldwell CW
Prostate; 2007 Aug; 67(11):1174-81. PubMed ID: 17516571
[TBL] [Abstract][Full Text] [Related]
16. Cancer incidence after localized therapy for prostate cancer.
Moon K; Stukenborg GJ; Keim J; Theodorescu D
Cancer; 2006 Sep; 107(5):991-8. PubMed ID: 16878323
[TBL] [Abstract][Full Text] [Related]
17. Incidence of second cancer within 5 years of diagnosis of a breast, prostate or colorectal cancer: a population-based study.
Cluze C; Delafosse P; Seigneurin A; Colonna M
Eur J Cancer Prev; 2009 Sep; 18(5):343-8. PubMed ID: 19436213
[TBL] [Abstract][Full Text] [Related]
18. Tumor recurrence in the remnant urothelium of females undergoing radical cystectomy for transitional cell carcinoma of the bladder: long-term results from a single center.
Akkad T; Gozzi C; Deibl M; Müller T; Pelzer AE; Pinggera GM; Bartsch G; Steiner H
J Urol; 2006 Apr; 175(4):1268-71; discussion 1271. PubMed ID: 16515977
[TBL] [Abstract][Full Text] [Related]
19. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.
Liauw SL; Sylvester JE; Morris CG; Blasko JC; Grimm PD
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):669-73. PubMed ID: 16887293
[TBL] [Abstract][Full Text] [Related]
20. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance.
Shen SS; Lerner SP; Muezzinoglu B; Truong LD; Amiel G; Wheeler TM
Hum Pathol; 2006 Jun; 37(6):726-34. PubMed ID: 16733214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
